{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T12:44:29Z","timestamp":1791549869943,"version":"4.3.4"},"reference-count":176,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000053","name":"National Institutes of Health\/ National Eye Institute","doi-asserted-by":"publisher","award":["R01EY025641"],"award-info":[{"award-number":["R01EY025641"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Institutes of Health\/ National Eye Institute","doi-asserted-by":"publisher","award":["R01EY031939"],"award-info":[{"award-number":["R01EY031939"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Institutes of Health\/ National Eye Institute","doi-asserted-by":"publisher","award":["R01EY035159"],"award-info":[{"award-number":["R01EY035159"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["RGPIN-2025-04563"],"award-info":[{"award-number":["RGPIN-2025-04563"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013779","name":"Retina Research Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100013779","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000196","name":"Canada Foundation for Innovation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000196","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>Ophthalmic drug delivery encounters unique challenges due to the anatomical and physiological ocular barriers, necessitating the development of novel drug delivery systems (NDDSs). This review focuses on emerging therapeutic platforms, including nanoemulsions (NEs), microemulsions (MEs), self-emulsifying drug delivery systems (SEDDSs) such as self-nano emulsifying drug delivery systems (SNEDDSs) and self-micro emulsifying drug delivery systems (SMEDDSs), emulgels, and in situ-forming emulgels, as novel strategies for enhancing ocular drug delivery. NEs and MEs, due to their small globule size, excellent drug solubility, stability, and bioavailability, offer promising solutions for effective ocular therapy. SEDDSs further enhance the stability and bioavailability of hydrophobic drugs through self-emulsification in aqueous environments. Emulgels, combining the benefits of emulsions and gels, provide sustained and controlled release of therapeutic agents, improving the ocular retention time and therapeutic efficacy. Additionally, in situ-forming emulgels offer the advantage of liquid-to-gel transition upon contact with ocular surfaces, optimizing drug delivery. The review discusses various ocular diseases, challenges for ocular delivery of conventional formulations, updates on emulsion-based novel drug delivery systems for ophthalmic drug delivery, mechanisms of enhanced ocular permeation, formulation strategies, advantages, and challenges, design-of-experiment considerations for optimization, characterizations, and recent advancements in these systems including patents and clinical trials, highlighting their potential for improving the treatment of various ocular diseases. Furthermore, this review explores marketed ophthalmic emulsions and future prospects for integrating these NDDSs into clinical ophthalmology, emphasizing their ability to overcome ocular barriers and enhance therapeutic efficacy.<\/jats:p>","DOI":"10.3390\/pharmaceutics17121504","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T08:59:46Z","timestamp":1763715586000},"page":"1504","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Emulsion and Emulgel-Based Ophthalmic Drug Delivery Systems"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3044-8706","authenticated-orcid":false,"given":"Debadatta","family":"Mohapatra","sequence":"first","affiliation":[{"name":"Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON M5S 3M2, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-2329-3016","authenticated-orcid":false,"given":"Eleen","family":"Yang","sequence":"additional","affiliation":[{"name":"Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON M5S 3M2, Canada"},{"name":"Temerty Faculty of Medicine, University of Toronto, Toronto, ON M5S 3M2, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1402-7875","authenticated-orcid":false,"given":"Timothy W.","family":"Corson","sequence":"additional","affiliation":[{"name":"Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON M5S 3M2, Canada"},{"name":"Temerty Faculty of Medicine, University of Toronto, Toronto, ON M5S 3M2, Canada"},{"name":"Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, ON M5S 3M2, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,11,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.jconrel.2023.01.018","article-title":"Nanotechnology based drug delivery systems for the treatment of anterior segment eye diseases","volume":"354","author":"Onugwu","year":"2023","journal-title":"J. Control. Release"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e23810","DOI":"10.1016\/j.heliyon.2023.e23810","article-title":"Overview of processed excipients in ocular drug delivery: Opportunities so far and bottlenecks","volume":"10","author":"Ashique","year":"2024","journal-title":"Heliyon"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.jconrel.2020.10.025","article-title":"Therapeutic nanoemulsions in ophthalmic drug administration: Concept in formulations and characterization techniques for ocular drug delivery","volume":"328","author":"Singh","year":"2020","journal-title":"J. Control. Release"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Fernandes, A.R., Sanchez-Lopez, E., dos Santos, T., Garcia, M.L., Silva, A.M., and Souto, E.B. (2021). Development and characterization of nanoemulsions for ophthalmic applications: Role of cationic surfactants. Materials, 14.","DOI":"10.3390\/ma14247541"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Smail, S.S., Ghareeb, M.M., Omer, H.K., Al-Kinani, A.A., and Alany, R.G. (2021). Studies on surfactants, cosurfactants, and oils for prospective use in formulation of ketorolac tromethamine ophthalmic nanoemulsions. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13040467"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Tsung, T.-H., Chen, Y.-H., and Lu, D.-W. (2023). Updates on biodegradable formulations for ocular drug delivery. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15030734"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1080\/09273948.2017.1333622","article-title":"Ocular self-microemulsifying drug delivery system of prednisolone improves therapeutic effectiveness in the treatment of experimental uveitis","volume":"27","author":"Tiwari","year":"2019","journal-title":"Ocul. Immunol. Inflamm."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"114867","DOI":"10.1016\/j.addr.2023.114867","article-title":"Non-aqueous formulations in topical ocular drug delivery\u2014A paradigm shift?","volume":"198","author":"Agarwal","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_9","first-page":"5576","article-title":"Self-Nano Emulsifying Drug delivery system (SNEEDS) for Ocular Administration","volume":"13","author":"Khan","year":"2020","journal-title":"Res. J. Pharm. Technol."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Serrano, A.C.C.L., Viana, M.C., Pinto, N.V., Lages, E.B., Carneiro, G., and Borges, G.S.M. (2025). The Use of Design of Experiments (DoE) Approaches for the Development of Self-Emulsifying Drug Delivery Systems (SEDDS). Appl. Nano, 6.","DOI":"10.3390\/applnano6010004"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Uttreja, P., Karnik, I., Adel Ali Youssef, A., Narala, N., Elkanayati, R.M., Baisa, S., Alshammari, N.D., Banda, S., Vemula, S.K., and Repka, M.A. (2025). Self-Emulsifying Drug Delivery Systems (SEDDS): Transition from liquid to solid\u2014a comprehensive review of formulation, characterization, applications, and future trends. Pharmaceutics, 17.","DOI":"10.3390\/pharmaceutics17010063"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"459","DOI":"10.13005\/bbra\/2931","article-title":"Emulgel approach to formulation development: A review","volume":"18","author":"Patel","year":"2021","journal-title":"Biosci. Biotechnol. Res. Asia"},{"key":"ref_13","first-page":"30","article-title":"A review on emulgel, as a novel trend in topical drug delivery system","volume":"1","author":"Jain","year":"2019","journal-title":"Recent Trends Pharm. Sci. Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/17425247.2024.2439457","article-title":"Versatility of emulgel in topical drug delivery transforming its expedition from bench to bedside","volume":"22","author":"Kumbhar","year":"2025","journal-title":"Expert Opin. Drug Deliv."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"101373","DOI":"10.1016\/j.jddst.2019.101373","article-title":"Formulation and optimization of microemulsion based sparfloxacin in-situ gel for ocular delivery: In vitro and ex vivo characterization","volume":"55","author":"Dhaval","year":"2020","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"116751","DOI":"10.1016\/j.molliq.2021.116751","article-title":"A comprehensive review on nanoemulsion as an ophthalmic drug delivery system","volume":"339","author":"Choradiya","year":"2021","journal-title":"J. Mol. Liq."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"652","DOI":"10.4274\/tjps.galenos.2020.59319","article-title":"Nanoemulsions as ophthalmic drug delivery systems","volume":"18","author":"Dhahir","year":"2021","journal-title":"Turk. J. Pharm. Sci."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.2174\/0113816128350573241202105210","article-title":"Selection criteria for oils, surfactants, and co-surfactants in ocular nanoemulsion formulation: A mini review","volume":"31","author":"Kishore","year":"2025","journal-title":"Curr. Pharm. Des."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S1773-2247(11)50010-3","article-title":"Emulsions and microemulsions for ocular drug delivery","volume":"21","author":"Peng","year":"2011","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"ref_20","first-page":"826798","article-title":"Microemulsion: New insights into the ocular drug delivery","volume":"2013","author":"Hegde","year":"2013","journal-title":"Int. Sch. Res. Not."},{"key":"ref_21","first-page":"1","article-title":"A review on novel nanoemulgel for ocular drug delivery","volume":"10","author":"Chauhan","year":"2024","journal-title":"EPH Int. J. Med. Health Sci."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Cassano, R., Di Gioia, M.L., and Trombino, S. (2021). Gel-based materials for ophthalmic drug delivery. Gels, 7.","DOI":"10.3390\/gels7030130"},{"key":"ref_23","unstructured":"Hashmi, M.F., Gurnani, B., and Benson, S. (2024). Conjunctivitis. StatPearls, StatPearls Publishing."},{"key":"ref_24","first-page":"25158414211020152","article-title":"Pterygium: An update on pathophysiology, clinical features, and management","volume":"13","author":"Shahraki","year":"2021","journal-title":"Ther. Adv. Ophthalmol."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Palewski, M., Budnik, A., and Konopi\u0144ska, J. (2022). Evaluating the efficacy and safety of different pterygium surgeries: A review of the literature. Int. J. Environ. Res. Public Health, 19.","DOI":"10.3390\/ijerph191811357"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Van Acker, S.I., Van den Bogerd, B., Haagdorens, M., Siozopoulou, V., N\u00ed Dhubhghaill, S., Pintelon, I., and Koppen, C. (2021). Pterygium\u2014The good, the bad, and the ugly. Cells, 10.","DOI":"10.3390\/cells10071567"},{"key":"ref_27","first-page":"6","article-title":"Updates on the mechanism and management of Pterygium: A Brief Review","volume":"3","author":"Sakti","year":"2021","journal-title":"Eur. J. Med. Health Sci."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1177\/11206721221088259","article-title":"Dry eye disease, a prominent manifestation of systemic autoimmune disorders","volume":"32","year":"2022","journal-title":"Eur. J. Ophthalmol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/s41433-020-01339-3","article-title":"Infectious keratitis: An update on epidemiology, causative microorganisms, risk factors, and antimicrobial resistance","volume":"35","author":"Ting","year":"2021","journal-title":"Eye"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"102561","DOI":"10.1016\/j.jddst.2021.102561","article-title":"Enhanced ocular delivery of clotrimazole via loading into mucoadhesive microemulsion system: In vitro characterization and in vivo assessment","volume":"64","author":"Ahmed","year":"2021","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"101559","DOI":"10.1016\/j.clae.2021.101559","article-title":"Keratoconus: An updated review","volume":"45","author":"Carracedo","year":"2022","journal-title":"Contact Lens Anterior Eye"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/s41572-024-00565-3","article-title":"Keratoconus","volume":"10","author":"Singh","year":"2024","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.2147\/OPTH.S392665","article-title":"Keratoconus diagnosis and treatment: Recent advances and future directions","volume":"17","author":"Bui","year":"2023","journal-title":"Clin. Ophthalmol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"123704","DOI":"10.1016\/j.ijpharm.2023.123704","article-title":"Engineering a novel water-in-oil biocompatible microemulsion system for the ocular delivery of dexamethasone sodium phosphate in the treatment of acute uveitis","volume":"650","author":"Ishak","year":"2024","journal-title":"Int. J. Pharm."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"105406","DOI":"10.1016\/j.jddst.2024.105406","article-title":"Prednisolone loaded-cationic nanoemulsion formulation for uveitis management","volume":"92","author":"Attia","year":"2024","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Mahran, A., Ismail, S., and Allam, A.A. (2021). Development of triamcinolone acetonide-loaded microemulsion as a prospective ophthalmic delivery system for treatment of uveitis: In vitro and in vivo evaluation. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13040444"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"103872","DOI":"10.1016\/j.jddst.2022.103872","article-title":"Enhanced anti-cataract effect of microemulsion containing Cineraria maritima: Formulation, optimization and in vivo evaluation","volume":"77","author":"Durgapal","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"ref_38","first-page":"e22003","article-title":"Postoperative endophthalmitis after cataract surgery: An update","volume":"14","author":"Althiabi","year":"2022","journal-title":"Cureus"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1159\/000533937","article-title":"Suprachoroidal hemorrhage","volume":"246","author":"Mohan","year":"2023","journal-title":"Ophthalmologica"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Kishore, A., Mahor, A.K., Singh, N.K., Singh, P.P., Rathore, P., and Bansal, K.K. (2024). Oil-in-water nanoemulsions for glaucoma treatment: An insight into the latest trends. Bioimpacts, 15.","DOI":"10.34172\/bi.2024.30224"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1093\/toxres\/tfaa066","article-title":"Investigating the ocular toxicity potential and therapeutic efficiency of in situ gel nanoemulsion formulations of brinzolamide","volume":"9","author":"Talaei","year":"2020","journal-title":"Toxicol. Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1208\/s12249-022-02459-7","article-title":"The development and evaluation of phase transition microemulsion for ocular delivery of acetazolamide for glaucoma treatment","volume":"24","author":"Essa","year":"2022","journal-title":"AAPS PharmSciTech"},{"key":"ref_43","first-page":"37","article-title":"Optimization of brinzolamide loaded microemulsion using formulation by design approach: Characterization and in-vitro evaluation","volume":"15","author":"Gohil","year":"2020","journal-title":"Curr. Drug Ther."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/ceo.14028","article-title":"The surgical management of glaucoma: A review","volume":"50","author":"Lim","year":"2022","journal-title":"Clin. Exp. Ophthalmol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.mcna.2021.01.003","article-title":"Age-related macular degeneration","volume":"105","author":"Thomas","year":"2021","journal-title":"Med. Clin. N. Am."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Burhan, A.M., Klahan, B., Cummins, W., Andr\u00e9s-Guerrero, V., Byrne, M.E., O\u2019Reilly, N.J., Chauhan, A., Fitzhenry, L., and Hughes, H. (2021). Posterior segment ophthalmic drug delivery: Role of muco-adhesion with a special focus on chitosan. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13101685"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1001\/jama.2023.26074","article-title":"Age-related macular degeneration: A review","volume":"331","author":"Fleckenstein","year":"2024","journal-title":"Jama"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2306479","DOI":"10.1002\/smll.202306479","article-title":"Long-Acting Microparticle Formulation of Griseofulvin for Ocular Neovascularization Therapy","volume":"20","author":"Chobisa","year":"2024","journal-title":"Small"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Yang, Z., Tan, T.-E., Shao, Y., Wong, T.Y., and Li, X. (2022). Classification of diabetic retinopathy: Past, present and future. Front. Endocrinol., 13.","DOI":"10.3389\/fendo.2022.1079217"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Tan, T.-E., and Wong, T.Y. (2023). Diabetic retinopathy: Looking forward to 2030. Front. Endocrinol., 13.","DOI":"10.3389\/fendo.2022.1077669"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Seo, H., Park, S.-J., and Song, M. (2025). Diabetic retinopathy (DR): Mechanisms, current therapies, and emerging strategies. Cells, 14.","DOI":"10.3390\/cells14050376"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.preteyeres.2015.08.001","article-title":"The progress in understanding and treatment of diabetic retinopathy","volume":"51","author":"Stitt","year":"2016","journal-title":"Prog. Retin. Eye Res."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Nguyen, X.-T.-A., Moekotte, L., Plomp, A.S., Bergen, A.A., van Genderen, M.M., and Boon, C.J. (2023). Retinitis pigmentosa: Current clinical management and emerging therapies. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24087481"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.2147\/OPTH.S365486","article-title":"Retinitis pigmentosa: Burden of disease and current unmet needs","volume":"16","author":"Cross","year":"2022","journal-title":"Clin. Ophthalmol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/APO.0000000000000227","article-title":"Retinitis pigmentosa: Progress and perspective","volume":"5","author":"Zhang","year":"2016","journal-title":"Asia Pac. J. Ophthalmol."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Li, S., Chen, L., and Fu, Y. (2023). Nanotechnology-based ocular drug delivery systems: Recent advances and future prospects. J. Nanobiotechnology, 21.","DOI":"10.1186\/s12951-023-01992-2"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s13346-016-0339-2","article-title":"A comprehensive insight on ocular pharmacokinetics","volume":"6","author":"Agrahari","year":"2016","journal-title":"Drug Deliv. Transl. Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"100145","DOI":"10.1016\/j.dmd.2025.100145","article-title":"Characterization of hydrolase activity in ocular tissues of humans and preclinical species","volume":"53","author":"Li","year":"2025","journal-title":"Drug Metab. Dispos."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"507","DOI":"10.2174\/1389200043335342","article-title":"Role of metabolism in ocular drug delivery","volume":"5","author":"Duvvuri","year":"2004","journal-title":"Curr. Drug Metab."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"100162","DOI":"10.1016\/j.medidd.2023.100162","article-title":"Microemulsions for enhancing drug delivery of hydrophilic drugs: Exploring various routes of administration","volume":"20","author":"Yadav","year":"2023","journal-title":"Med. Drug Discov."},{"key":"ref_61","first-page":"3054","article-title":"The effect of intraocular pressure on human and rabbit scleral permeability","volume":"40","author":"Rudnick","year":"1999","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Bachu, R.D., Chowdhury, P., Al-Saedi, Z.H., Karla, P.K., and Boddu, S.H. (2018). Ocular drug delivery barriers\u2014Role of nanocarriers in the treatment of anterior segment ocular diseases. Pharmaceutics, 10.","DOI":"10.3390\/pharmaceutics10010028"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Shastri, D.H., Silva, A.C., and Almeida, H. (2023). Ocular delivery of therapeutic proteins: A review. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15010205"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.2147\/OPTH.S118409","article-title":"Systemic side effects of eye drops: A pharmacokinetic perspective","volume":"10","author":"Farkouh","year":"2016","journal-title":"Clin. Ophthalmol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"28","DOI":"10.34172\/apb.2021.003","article-title":"A review on ocular novel drug delivery systems of antifungal drugs: Functional evaluation and comparison of conventional and novel dosage forms","volume":"11","author":"Mehrandish","year":"2020","journal-title":"Adv. Pharm. Bull."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1080\/17425247.2018.1496080","article-title":"Recent advance of nanoparticle-based topical drug delivery to the posterior segment of the eye","volume":"15","author":"Wang","year":"2018","journal-title":"Expert Opin. Drug Deliv."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Ibrahim, M.M., Maria, D.N., Wang, X., Simpson, R.N., Hollingsworth, T., and Jablonski, M.M. (2020). Enhanced corneal penetration of a poorly permeable drug using bioadhesive multiple microemulsion technology. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12080704"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ijpharm.2017.05.005","article-title":"Microemulsion utility in pharmaceuticals: Implications for multi-drug delivery","volume":"526","author":"Callender","year":"2017","journal-title":"Int. J. Pharm."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Souto, E.B., Cano, A., Martins-Gomes, C., Coutinho, T.E., Zieli\u0144ska, A., and Silva, A.M. (2022). Microemulsions and nanoemulsions in skin drug delivery. Bioengineering, 9.","DOI":"10.3390\/bioengineering9040158"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1039\/C2SM06903B","article-title":"Nanoemulsions versus microemulsions: Terminology, differences, and similarities","volume":"8","author":"McClements","year":"2012","journal-title":"Soft Matter"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"119559","DOI":"10.1016\/j.molliq.2022.119559","article-title":"In situ gelling microemulsion for topical ocular delivery of moxifloxacin and betamethasone","volume":"360","author":"Cardoso","year":"2022","journal-title":"J. Mol. Liq."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.msec.2019.01.137","article-title":"Studies on olive-and silicone-oils-based Janus macroemulsions containing ginger to manage primary dysmenorrheal pain","volume":"100","author":"Puri","year":"2019","journal-title":"Mater. Sci. Eng. C"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1021\/la950359e","article-title":"Macroemulsion Stability:\u2009 The oriented wedge theory revisited","volume":"12","author":"Kabalnov","year":"1996","journal-title":"Langmuir"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.2174\/1567201819666220914113324","article-title":"A comprehensive insight on recent advancements in self-emulsifying drug delivery systems","volume":"20","author":"Kadian","year":"2023","journal-title":"Curr. Drug Deliv."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2174\/0122117385280541231130055458","article-title":"Overcoming solubility challenges: Self-emulsifying systems for enhancing the delivery of poorly water-soluble antiviral drugs","volume":"13","author":"Kapoor","year":"2025","journal-title":"Pharm. Nanotechnol."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"El Maghraby, G.M., Arafa, M.F., and Sultan, A.A. (2023). Self-emulsifying systems for drug delivery: Advances and challenges. Advanced and Modern Approaches for Drug Delivery, Academic Press.","DOI":"10.1016\/B978-0-323-91668-4.00030-7"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"123840","DOI":"10.1016\/j.ijpharm.2024.123840","article-title":"Triamcinolone-loaded self nano-emulsifying drug delivery systems for ocular use: An alternative to invasive ocular surgeries and injections","volume":"653","author":"Dehghani","year":"2024","journal-title":"Int. J. Pharm."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1080\/10717544.2021.1986601","article-title":"A comprehensive study of the basic formulation of supersaturated self-nanoemulsifying drug delivery systems (SNEDDS) of albendazolum","volume":"28","author":"Alothaid","year":"2021","journal-title":"Drug Deliv."},{"key":"ref_79","first-page":"1","article-title":"SNEDDS as lipid-based nanocarrier systems: Concepts and formulation insights","volume":"14","author":"Gottemukkula","year":"2022","journal-title":"Int. J. Appl. Pharm."},{"key":"ref_80","first-page":"1","article-title":"Self nano-emulsifying drug delivery system: A review","volume":"12","author":"Divate","year":"2021","journal-title":"J. Adv. Sci. Res."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Zingale, E., Bonaccorso, A., D\u2019Amico, A.G., Lombardo, R., D\u2019Agata, V., Rautio, J., and Pignatello, R. (2024). Formulating resveratrol and melatonin self-nanoemulsifying drug delivery systems (SNEDDS) for ocular administration using design of experiments. Pharmaceutics, 16.","DOI":"10.3390\/pharmaceutics16010125"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"104226","DOI":"10.1016\/j.jddst.2023.104226","article-title":"Formulation and evaluation of ocular self-nanoemulsifying drug delivery system of brimonidine tartrate","volume":"81","author":"Vikash","year":"2023","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"131","DOI":"10.13189\/app.2023.110205","article-title":"Novel approach self-nanoemulsifying drug delivery system: A review","volume":"11","author":"Suyal","year":"2023","journal-title":"Adv. Pharmacol. Pharm."},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Youssef, A.A.A., Thakkar, R., Senapati, S., Joshi, P.H., Dudhipala, N., and Majumdar, S. (2022). Design of topical moxifloxacin mucoadhesive nanoemulsion for the management of ocular bacterial infections. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14061246"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ejps.2017.04.013","article-title":"Nanoemulsion-based electrolyte triggered in situ gel for ocular delivery of acetazolamide","volume":"104","author":"Morsi","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"7631","DOI":"10.1007\/s00289-023-05095-8","article-title":"Biopolymer-based nano-formulations for mitigation of ocular infections: A review","volume":"81","author":"Karati","year":"2024","journal-title":"Polym. Bull."},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Islam, S., Giri, Y., and Pattnaik, G. (2025). Development and optimization of levofloxacin in-situ emulgel to manage ocular bacterial infections. Not. Sci. Biol., 17.","DOI":"10.55779\/nsb17112331"},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Donthi, M.R., Munnangi, S.R., Krishna, K.V., Saha, R.N., Singhvi, G., and Dubey, S.K. (2023). Nanoemulgel: A novel nano carrier as a tool for topical drug delivery. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15010164"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"12","DOI":"10.2174\/0118764029316500240904074317","article-title":"Nanoemulgel: A comprehensive review of formulation strategies, characterization, patents and applications","volume":"17","author":"Ansari","year":"2025","journal-title":"Micro Nanosyst."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"103420","DOI":"10.1016\/j.jddst.2022.103420","article-title":"Nanoemulgel as an approach to improve the biopharmaceutical performance of lipophilic drugs: Contemporary research and application","volume":"72","author":"Ahmad","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"14","DOI":"10.18231\/j.joapr.2021.v9.i3.14-20","article-title":"Microemulgel: A novel approach for topical drug delivery","volume":"9","author":"Kushwah","year":"2021","journal-title":"J. Appl. Pharm. Res."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"171","DOI":"10.52711\/0975-4377.2022.00027","article-title":"Novel topical drug delivery system: Microemulgel-A Review","volume":"14","author":"Mehta","year":"2022","journal-title":"Res. J. Pharm. Dos. Forms Technol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"101400","DOI":"10.1016\/j.jddst.2019.101400","article-title":"Development of thermosensitive in situ gel nanoemulsions for ocular delivery of acyclovir","volume":"55","author":"Mahboobian","year":"2020","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Mazyed, E.A., and Abdelaziz, A.E. (2020). Fabrication of transgelosomes for enhancing the ocular delivery of acetazolamide: Statistical optimization, in vitro characterization, and in vivo study. Pharmaceutics, 12.","DOI":"10.3390\/pharmaceutics12050465"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"119402","DOI":"10.1016\/j.ijpharm.2020.119402","article-title":"Nanoemulsion as a feasible and biocompatible carrier for ocular delivery of travoprost: Improved pharmacokinetic\/pharmacodynamic properties","volume":"583","author":"Ismail","year":"2020","journal-title":"Int. J. Pharm."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"124252","DOI":"10.1016\/j.ijpharm.2024.124252","article-title":"Development of ophthalmic nanoemulsions of \u03b2-caryophyllene for the treatment of Acanthamoeba keratitis","volume":"659","author":"Porto","year":"2024","journal-title":"Int. J. Pharm."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"413","DOI":"10.56808\/3027-7922.2623","article-title":"Design, development, and characterization of brinzolamide and brimonidine tartrate nanoemulsion for ophthalmic drug delivery","volume":"46","author":"Choradiya","year":"2022","journal-title":"Thai J. Pharm. Sci."},{"key":"ref_98","first-page":"93","article-title":"Design of novel nanoemulsion formulations for topical ocular delivery of itraconazole: Development, characterization and in vitro bioassay","volume":"12","author":"Mehrandish","year":"2021","journal-title":"Adv. Pharm. Bull."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Youssef, A.A.A., Cai, C., Dudhipala, N., and Majumdar, S. (2021). Design of topical ocular ciprofloxacin nanoemulsion for the management of bacterial keratitis. Pharmaceuticals, 14.","DOI":"10.3390\/ph14030210"},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Yang, J., Liang, Z., Lu, P., Song, F., Zhang, Z., Zhou, T., Li, J., and Zhang, J. (2022). Development of a luliconazole nanoemulsion as a prospective ophthalmic delivery system for the treatment of fungal keratitis: In vitro and in vivo evaluation. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14102052"},{"key":"ref_101","first-page":"1058","article-title":"Design, preparation and in-vitro evaluation of novel ocular antifungal nanoemulsion using posaconazole as a model drug","volume":"11","author":"Nasser","year":"2021","journal-title":"Int. J. Drug Deliv. Technol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s13346-021-00902-z","article-title":"Besifloxacin-loaded ocular nanoemulsions: Design, formulation and efficacy evaluation","volume":"12","author":"Kassaee","year":"2022","journal-title":"Drug Deliv. Transl. Res."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1080\/10717544.2022.2096714","article-title":"Preparation and in vitro and in vivo evaluation of an isoliquiritigenin-loaded ophthalmic nanoemulsion for the treatment of corneal neovascularization","volume":"29","author":"Zhang","year":"2022","journal-title":"Drug Deliv."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"e29009","DOI":"10.1016\/j.heliyon.2024.e29009","article-title":"Evaluation of curcumin-based ophthalmic nano-emulsion on atropine-induced dry eye in mice","volume":"10","author":"Jahromy","year":"2024","journal-title":"Heliyon"},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Gawin-Miko\u0142ajewicz, A., Nawrot, U., Malec, K.H., Krajewska, K., Nartowski, K.P., and Karolewicz, B.L. (2023). The effect of high-pressure homogenization conditions on the physicochemical properties and stability of designed fluconazole-loaded ocular nanoemulsions. Pharmaceutics, 16.","DOI":"10.3390\/pharmaceutics16010011"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1007\/s13346-022-01271-x","article-title":"Studies on spray dried topical ophthalmic emulsions containing cyclosporin A (0.05% w\/w): Systematic optimization, in vitro preclinical toxicity and in vivo assessments","volume":"13","author":"Rahman","year":"2023","journal-title":"Drug Deliv. Transl. Res."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"124755","DOI":"10.1016\/j.colsurfa.2020.124755","article-title":"Cationic rifampicin nanoemulsion for the treatment of ocular tuberculosis","volume":"597","author":"Henostroza","year":"2020","journal-title":"Colloids Surf. A Physicochem. Eng. Asp."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"103047","DOI":"10.1016\/j.jddst.2021.103047","article-title":"Formulation and optimization of cationic nanoemulsions for enhanced ocular delivery of dorzolamide hydrochloride using Box-Behnken design: In vitro and in vivo assessments","volume":"68","author":"Kassem","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"886","DOI":"10.3109\/10717544.2014.920432","article-title":"Delivery of gatifloxacin using microemulsion as vehicle: Formulation, evaluation, transcorneal permeation and aqueous humor drug determination","volume":"23","author":"Kalam","year":"2016","journal-title":"Drug Deliv."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"e127486","DOI":"10.5812\/ijpr-127486","article-title":"Ocular delivery of quercetin using microemulsion system: Design, characterization, and ex-vivo transcorneal permeation","volume":"21","author":"Moghimipour","year":"2022","journal-title":"Iran. J. Pharm. Res."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/10717544.2021.2021323","article-title":"Development of a naringenin microemulsion as a prospective ophthalmic delivery system for the treatment of corneal neovascularization: In vitro and in vivo evaluation","volume":"29","author":"Ma","year":"2022","journal-title":"Drug Deliv."},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Shi, J., Yang, J., Xu, H., Luo, Q., Sun, J., Zhang, Y., Liang, Z., Zhao, N., and Zhang, J. (2023). Preparation of a Sunitinib loaded microemulsion for ocular delivery and evaluation for the treatment of corneal neovascularization in vitro and in vivo. Front. Pharmacol., 14.","DOI":"10.3389\/fphar.2023.1157084"},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Santonocito, M., Zappulla, C., Viola, S., La Rosa, L.R., Solfato, E., Abbate, I., Tarallo, V., Apicella, I., Platania, C.B.M., and Maugeri, G. (2021). Assessment of a new nanostructured microemulsion system for ocular delivery of sorafenib to posterior segment of the eye. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22094404"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"925","DOI":"10.35333\/JRP.2020.252","article-title":"Ocular delivery of ketorolac tromethamine using microemulsion as a vehicle: Design, evaluation, and transcorneal permeation","volume":"24","author":"Salimi","year":"2020","journal-title":"J. Res. Pharm."},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Zhang, Y., Yang, J., Ji, Y., Liang, Z., Wang, Y., and Zhang, J. (2023). Development of osthole-loaded microemulsions as a prospective ocular delivery system for the treatment of corneal neovascularization: In vitro and in vivo assessments. Pharmaceuticals, 16.","DOI":"10.3390\/ph16101342"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s10792-022-02514-z","article-title":"Role of mucoadhesive agent in ocular delivery of ganciclovir microemulsion: Cytotoxicity evaluation in vitro and ex vivo","volume":"43","author":"Choudhari","year":"2023","journal-title":"Int. Ophthalmol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"7928","DOI":"10.1021\/acsomega.9b04244","article-title":"Triamcinolone acetonide-loaded PEGylated microemulsion for the posterior segment of eye","volume":"5","author":"Nayak","year":"2020","journal-title":"ACS Omega"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1080\/09205063.2020.1740964","article-title":"PEGylated microemulsion for dexamethasone delivery to posterior segment of eye","volume":"31","author":"Nayak","year":"2020","journal-title":"J. Biomater. Sci. Polym. Ed."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1177\/08839115231167587","article-title":"Fabrication of poloxamer based besifloxacin thermosensitive in situ gelling nanoemulsions for ophthalmic delivery","volume":"38","author":"Kassaee","year":"2023","journal-title":"J. Bioact. Compat. Polym."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1167\/tvst.11.5.16","article-title":"Delivery of hydrophobic drugs to the posterior ocular region by gel-in-water nanoemulsion","volume":"11","author":"Fardous","year":"2022","journal-title":"Transl. Vis. Sci. Technol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.21608\/ejhm.2023.284303","article-title":"Formulation and evaluation of prednisolone acetate microemulsion ocular gel","volume":"90","year":"2023","journal-title":"Egypt. J. Hosp. Med."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4103\/jpbs.JPBS_338_20","article-title":"Formulation and evaluation of levofloxacin and betamethasone ophthalmic emulgel","volume":"13","author":"Sabry","year":"2021","journal-title":"J. Pharm. Bioallied Sci."},{"key":"ref_123","first-page":"127","article-title":"Novel in-situ emulgel of acetazolamide for ocular drug delivery","volume":"13","author":"Ali","year":"2023","journal-title":"J. Appl. Pharm. Sci."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1080\/02713683.2021.1929328","article-title":"Acyclovir-loaded nanoemulsions: Preparation, characterization and irritancy studies for ophthalmic delivery","volume":"46","author":"Mohammadi","year":"2021","journal-title":"Curr. Eye Res."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1080\/15376516.2021.1941461","article-title":"Studying the ophthalmic toxicity potential of developed ketoconazole loaded nanoemulsion in situ gel formulation for ophthalmic administration","volume":"31","author":"Tavakoli","year":"2021","journal-title":"Toxicol. Mech. Methods"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1208\/s12249-022-02211-1","article-title":"Non-ionic surfactants as a P-glycoprotein (P-gp) efflux inhibitor for optimal drug delivery\u2014A concise outlook","volume":"23","author":"Rathod","year":"2022","journal-title":"AAPS PharmSciTech"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s11671-025-04234-6","article-title":"Ocular drug delivery systems based on nanotechnology: A comprehensive review for the treatment of eye diseases","volume":"20","author":"Bairagi","year":"2025","journal-title":"Discov. Nano"},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"Jacob, S., Kather, F.S., Boddu, S.H., Shah, J., and Nair, A.B. (2024). Innovations in nanoemulsion technology: Enhancing drug delivery for oral, parenteral, and ophthalmic applications. Pharmaceutics, 16.","DOI":"10.3390\/pharmaceutics16101333"},{"key":"ref_129","first-page":"329","article-title":"Study of penetration mechanism of labrasol on rabbit cornea by Ussing chamber, RT-PCR assay, Western blot and immunohistochemistry","volume":"14","author":"Guo","year":"2019","journal-title":"Asian J. Pharm. Sci."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.colsurfb.2016.08.048","article-title":"Improving the topical ocular pharmacokinetics of an immunosuppressant agent with mucoadhesive nanoemulsions: Formulation development, in-vitro and in-vivo studies","volume":"148","author":"Akhter","year":"2016","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_131","first-page":"1105","article-title":"Topical emulgel: Basic considerations in development and advanced research","volume":"84","author":"Malavi","year":"2022","journal-title":"Indian J. Pharm. Sci."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jconrel.2013.06.030","article-title":"Recent expansions in an emergent novel drug delivery technology: Emulgel","volume":"171","author":"Ajazuddin","year":"2013","journal-title":"J. Control. Release"},{"key":"ref_133","doi-asserted-by":"crossref","unstructured":"Hidajat, M.J., Jo, W., Kim, H., and Noh, J. (2020). Effective droplet size reduction and excellent stability of limonene nanoemulsion formed by high-pressure homogenizer. Colloids Interfaces, 4.","DOI":"10.3390\/colloids4010005"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"125","DOI":"10.69613\/3f8m9151","article-title":"Nanoemulsion formulation strategies for enhanced drug delivery","volume":"2","author":"Tanuku","year":"2024","journal-title":"J. Pharma Insights Res."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"650","DOI":"10.3855\/jidc.6842","article-title":"Essential oils in ocular pathology: An experimental study","volume":"9","author":"Cannas","year":"2015","journal-title":"J. Infect. Dev. Ctries."},{"key":"ref_136","doi-asserted-by":"crossref","unstructured":"Maiti, S., Sadhukhan, S., and Bakshi, P. (2016). Ocular preservatives: Risks and recent trends in its application in ocular drug delivery (ODD). Nano-Biomaterials for Ophthalmic Drug Delivery, Springer.","DOI":"10.1007\/978-3-319-29346-2_13"},{"key":"ref_137","first-page":"121","article-title":"Therapeutic challenges in ocular delivery of lipid based emulsion","volume":"5","author":"Tiwari","year":"2018","journal-title":"Egypt. J. Basic Appl. Sci."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1080\/20415990.2024.2363136","article-title":"Quality-by-design-based microemulsion of disulfiram for repurposing in melanoma and breast cancer therapy","volume":"15","author":"Mohapatra","year":"2024","journal-title":"Ther. Deliv."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"861904","DOI":"10.1155\/2014\/861904","article-title":"Ophthalmic drug dosage forms: Characterisation and research methods","volume":"2014","author":"Baranowski","year":"2014","journal-title":"Sci. World J."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1177\/2211068214561025","article-title":"TEER measurement techniques for in vitro barrier model systems","volume":"20","author":"Srinivasan","year":"2015","journal-title":"J. Lab. Autom."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"690","DOI":"10.5301\/ejo.5000248","article-title":"Effect of VEGF and anti-VEGF compounds on retinal pigment epithelium permeability: An in vitro study","volume":"23","author":"Campa","year":"2013","journal-title":"Eur. J. Ophthalmol."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0161-6420(99)90170-7","article-title":"Correlation of tear fluorescein clearance and Schirmer test scores with ocular irritation symptoms","volume":"106","author":"Afonso","year":"1999","journal-title":"Ophthalmology"},{"key":"ref_143","unstructured":"Brott, N.R., Zeppieri, M., and Ronquillo, Y. (2024). Schirmer test. StatPearls, StatPearls Publishing."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1007\/BF00789543","article-title":"Possibilities for the fluorometric detection of bacterial pyrogens","volume":"13","author":"Shchedrina","year":"1979","journal-title":"Pharm. Chem. J."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"911","DOI":"10.3109\/10717544.2013.861883","article-title":"Formulation and evaluation of Cyclosporin A emulgel for ocular delivery","volume":"22","author":"Shen","year":"2015","journal-title":"Drug Deliv."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/S2222-1808(14)60411-4","article-title":"Micro-emulsion based emulgel: A novel topical drug delivery system","volume":"4","author":"Ashara","year":"2014","journal-title":"Asian Pac. J. Trop. Dis."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ijpharm.2012.12.049","article-title":"Promising ion-sensitive in situ ocular nanoemulsion gels of terbinafine hydrochloride: Design, in vitro characterization and in vivo estimation of the ocular irritation and drug pharmacokinetics in the aqueous humor of rabbits","volume":"443","author":"Tayel","year":"2013","journal-title":"Int. J. Pharm."},{"key":"ref_148","unstructured":"(2025, October 04). Google Patents. Available online: https:\/\/patents.google.com\/patent\/US20240041974A1\/en."},{"key":"ref_149","unstructured":"(2025, October 04). Google Patents. Available online: https:\/\/patents.google.com\/patent\/US11173112B2\/en."},{"key":"ref_150","unstructured":"(2025, October 04). Google Patents. Available online: https:\/\/patents.google.com\/patent\/US20240307299A1\/en."},{"key":"ref_151","unstructured":"(2025, October 04). Google Patents. Available online: https:\/\/patents.google.com\/patent\/US11690802B2\/en."},{"key":"ref_152","unstructured":"(2025, October 04). Google Patents. Available online: https:\/\/patents.google.com\/patent\/US11234929B2\/en."},{"key":"ref_153","unstructured":"(2025, October 04). Google Patents. Available online: https:\/\/patents.google.com\/patent\/US8273366B2\/en."},{"key":"ref_154","unstructured":"(2025, October 04). Google Patents. Available online: https:\/\/patents.google.com\/patent\/US20210085603A1\/en."},{"key":"ref_155","unstructured":"(2025, October 04). Google Patents. Available online: https:\/\/patents.google.com\/patent\/US20190076354A1\/en."},{"key":"ref_156","unstructured":"(2025, October 04). Google Patents. Available online: https:\/\/patents.google.com\/patent\/KR102204221B1\/en."},{"key":"ref_157","unstructured":"(2025, October 04). Google Patents. Available online: https:\/\/patents.google.com\/patent\/US10555947B2\/en."},{"key":"ref_158","unstructured":"(2025, October 04). Google Patents. Available online: https:\/\/patents.google.com\/patent\/JP7642536B2\/en."},{"key":"ref_159","unstructured":"(2025, October 04). Google Patents. Available online: https:\/\/patents.google.com\/patent\/KR102407735B1\/en."},{"key":"ref_160","unstructured":"(2025, October 04). Google Patents. Available online: https:\/\/patents.google.com\/patent\/AU2013255231B2\/en."},{"key":"ref_161","unstructured":"(2025, October 04). Google Patents. Available online: https:\/\/patents.google.com\/patent\/US9597328B2\/en."},{"key":"ref_162","unstructured":"(2025, October 04). Google Patents. Available online: https:\/\/patents.google.com\/patent\/JP7489965B2\/en."},{"key":"ref_163","unstructured":"(2025, October 04). Google Patents. Available online: https:\/\/patents.google.com\/patent\/CN102159186B\/en."},{"key":"ref_164","unstructured":"(2025, October 04). Google Patents. Available online: https:\/\/patents.google.com\/patent\/JP2021107402A\/en."},{"key":"ref_165","unstructured":"(2025, October 04). Google Patents. Available online: https:\/\/patents.google.com\/patent\/EP2579845B1\/en."},{"key":"ref_166","unstructured":"(2025, October 04). Google Patents. Available online: https:\/\/patents.google.com\/patent\/US20180250313A1\/en."},{"key":"ref_167","unstructured":"(2025, October 04). Google Patents. Available online: https:\/\/patents.google.com\/patent\/JP2020037557A\/en."},{"key":"ref_168","unstructured":"(2025, October 04). Google Patents. Available online: https:\/\/patents.google.com\/patent\/ES2706535T3\/en."},{"key":"ref_169","unstructured":"(2025, October 04). Google Patents. Available online: https:\/\/patents.google.com\/patent\/US20180221278A1\/en."},{"key":"ref_170","unstructured":"(2025, October 04). Google Patents. Available online: https:\/\/patents.google.com\/patent\/US20230293557A1\/en."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"24926","DOI":"10.1039\/D5NR03888J","article-title":"Nanoemulsions for the ocular delivery of anti-infectives: Challenges, advances and prospects in treating infectious eye diseases","volume":"17","author":"Onugwu","year":"2025","journal-title":"Nanoscale"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"102792","DOI":"10.1016\/j.fochx.2025.102792","article-title":"Advances in emulsion stability: A review on mechanisms, role of emulsifiers, and applications in food","volume":"29","author":"Xiao","year":"2025","journal-title":"Food Chem. X"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.1021\/acs.molpharmaceut.1c00650","article-title":"Ophthalmic nanoemulsions: From composition to technological processes and quality control","volume":"18","author":"Nartowski","year":"2021","journal-title":"Mol. Pharm."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"30","DOI":"10.61554\/ijnrph.v2i1.2024.67","article-title":"Exploring the role of artificial intelligence and machine learning in pharmaceutical formulation design","volume":"2","author":"Dey","year":"2024","journal-title":"Int. J. Newgen Res. Pharm. Healthc."},{"key":"ref_175","doi-asserted-by":"crossref","unstructured":"Vora, L.K., Gholap, A.D., Jetha, K., Thakur, R.R.S., Solanki, H.K., and Chavda, V.P. (2023). Artificial intelligence in pharmaceutical technology and drug delivery design. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15071916"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s43094-024-00625-1","article-title":"Influence of artificial intelligence in modern pharmaceutical formulation and drug development","volume":"10","author":"Ali","year":"2024","journal-title":"Futur. J. Pharm. Sci."}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/17\/12\/1504\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,23]],"date-time":"2025-11-23T05:17:32Z","timestamp":1763875052000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/17\/12\/1504"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,21]]},"references-count":176,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["pharmaceutics17121504"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics17121504","relation":{},"ISSN":["1999-4923"],"issn-type":[{"value":"1999-4923","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,21]]}}}